where does the name guillain-barre syndrome come from
Guillain–Barré syndrome In those with severe weakness, prompt treatment with intravenous immunoglobulins or plasmapheresis, together with supportive care, will lead to good recovery in the majority.[2] Recovery may take weeks to years.[2] About a third have some permanent weakness.[2] Globally death occurs in about 7.5% of those affected.[1] Guillain–Barré syndrome is rare, at one or two cases per 100,000 people every year.[2][3] Both sexes and all parts of the world have similar rates of disease.[1][2] The syndrome is named after the French neurologists Georges Guillain and Jean Alexandre Barré, who described it with André Strohl in 1916.[5][6]
Fatal familial insomnia Fatal familial insomnia (FFI) is an extremely rare autosomal dominant inherited prion disease of the brain. It is almost always caused by a mutation to the protein PrPC, but can also develop spontaneously in patients with a non-inherited mutation variant called sporadic fatal insomnia (sFI). FFI has no known cure and involves progressively worsening insomnia, which leads to hallucinations, delirium, confusional states like that of dementia, and eventually, death.[1] The average survival time for patients diagnosed with FFI after the onset of symptoms is 18 months.[1]